Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19316
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Angiogenesis Inhibitors/administration & dosage/adverse effects/*therapeutic use,Chemotherapy, Adjuvant,Combined Modality Therapy,Constipation/chemically induced,Disease Progression,Female,Fibroblast Growth Factor 2/blood,Follow-Up Studies,Glioblastoma/drug therapy/radiotherapy,Glioma/*drug therapy/radiotherapy,Humans,Hypnotics and Sedatives/adverse effects,Male,Middle Aged,Neoplasm Recurrence, Local/*drug therapy,Peripheral Nervous System Diseases/chemically induced,Remission Induction,Supratentorial Neoplasms/*drug therapy/radiotherapy,Survival Rate,Thalidomide/administration & dosage/adverse effects/*therapeutic use,Tumor Markers, Biological/blood
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19316
ISSN: 0732-183X
Link: http://www.ncbi.nlm.nih.gov/pubmed/10673511
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons